Research examines effects of opioids on patients with sickle cell disease
Researchers from Virginia Commonwealth University (VCU) sought to shed light on the biopsychosocial and spiritual effects of taking prescribed opioids to treat noncancer pain. Such questions have received little examination ...
Medications
Apr 11, 2013 |
not rated yet |
0
Stem cells enable personalised treatment for bleeding disorder
(Medical Xpress)—Scientists have shed light on a common bleeding disorder by growing and analysing stem cells from patients' blood to discover the cause of the disease in individual patients.
Medical research
Apr 05, 2013 |
5 / 5 (1) |
0
|
Are there cerebral abnormalities in eating disorders?
A report from the University of Freiburg that is published in one of the last issue of Psychotherapy and Psychosomatics address the presence of cerebral abnormalities in eating disorders.
Psychology & Psychiatry
Apr 03, 2013 |
not rated yet |
0
Researchers study use of dasatinib for patients with high-risk MDS
Researchers at Moffitt Cancer Center have completed a phase II clinical trial to determine the safety and efficacy of dasatinib for patients with higher-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia, ...
Cancer
Mar 21, 2013 |
not rated yet |
0
Cellular bells: Key step in manufacture of red blood cells decoded
A healthy adult must generate as many as one hundred billion new red blood cells each day, to maintain the numbers circulating in his blood. A team of EPFL researchers has identified a key step in the process by which red ...
Medical research
Mar 14, 2013 |
5 / 5 (4) |
0
|
Persistence pays off in solving hemophilia mystery, showing curiosity drives discovery
An Australian researcher has found the third and final missing piece in the genetic puzzle of an unusual form of hemophilia, more than 20 year after he discovered the first two pieces.
Genetics
Mar 07, 2013 |
5 / 5 (1) |
0
|
Swiss Red Cross cuts blood supply to broke Greece
(AP)—The Swiss Red Cross is slashing its supply of donor blood to Greece because the financially stricken country has failed to pay its bills on time, the head of the group's transfusion service said Tuesday.
Other
Feb 26, 2013 |
5 / 5 (1) |
0
Facts on 'bute', pain drug found in horsemeat
Phenylbutazone, a painkiller for horses, can cause blood disorders in humans but at doses much higher than any one person is likely to ingest from eating horsemeat.
Other
Feb 14, 2013 |
not rated yet |
0
Higher risk of stroke from common heart disease
(Medical Xpress)—Australians are being warned of a higher risk of stroke caused by the nation's most common heart rhythm disorder, atrial fibrillation.
Cardiology
Feb 11, 2013 |
not rated yet |
0
|
Pomalyst approved for advanced multiple myeloma
(HealthDay)—Pomalyst (pomalidomide) has been approved by the U.S. Food and Drug Administration to treat cases of multiple myeloma that have not responded to other therapies.
Medications
Feb 09, 2013 |
not rated yet |
0
Yoga helps the heart, researchers say
The same kind of exercise that can bring peace to your mind may bring peace to your heart as well.
Cardiology
Feb 08, 2013 |
5 / 5 (1) |
0
New stroke gene discovery could lead to tailored treatments
An international study led by King's College London has identified a new genetic variant associated with stroke. By exploring the genetic variants linked with blood clotting – a process that can lead to a stroke – scientists ...
Neuroscience
Feb 01, 2013 |
5 / 5 (3) |
0
|
Brain activity predicts response to scopolamine
(HealthDay)—The neural response in the visual cortex while processing emotional information can predict which patients with major depressive disorder will respond to scopolamine, according to a study published ...
Psychology & Psychiatry
Jan 31, 2013 |
not rated yet |
0
Team discovers potential blood test for autistic patients
(Medical Xpress)—Results of a recent clinical study by researchers from Western and the University of Arkansas reveal the presence of a unique blood marker, which may further the understanding of possible gut linked environmental ...
Autism spectrum disorders
Jan 29, 2013 |
3.7 / 5 (3) |
0
|
Drug approved for inherited blood disorder
(HealthDay)—Exjade (deferasirox) has been approved by the U.S. Food and Drug Administration to remove excess iron in the blood among people with a genetic blood disorder called non-transfusion-dependent thalassemia (NTDT).
Medications
Jan 24, 2013 |
not rated yet |
0
